US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gladstone Investment

13.75

+0.02000.15%

Post-market: 13.880.1300+0.95%18:35 EDT

Volume:61.43K

Turnover:846.19K

Market Cap:506.51M

PE:7.18

High:13.88

Open:13.74

Low:13.70

Close:13.73

Loading ...

Overview Company News Filings

Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update

S&P CORELOGIC CASE-SHILLER INDEX RECORDS 3.9% ANNUAL GAIN IN FEBRUARY 2025

KIA EV6, EV9 AND NIRO OWNERS GAIN ACCESS TO OVER 21,500 TESLA SUPERCHARGERS

Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections

Gladstone Investment (GAIN) Moves 11.0% Higher: Will This Strength Last?

Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

Gladstone Investment Keeps Monthly Distributions; Declares Supplemental Distribution

MT Newswires Live

Gladstone Investment Announces Monthly Cash Distributions for April, May and June 2025, a Supplemental Distribution to Common Stockholders, and Earnings Release and Conference Call Dates for the Fourth Fiscal Quarter

ACCESS Newswire

42-Year-Old With $250K And A 'Failed Marriage, 3 Kids' Faces A Full Life Restart – 'How Would You Divide It Up?' Reddit Explodes With Advice

Gladstone Investment Corporation Exits Its Investment in Nocturne Luxury Villas

ACCESS Newswire

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update

Recce Pharmaceuticals Granted Japanese Patent for RECCE® Anti-Infectives

Gladstone Investment Corporation Expands its Investment in Pyrotek Special Effects via the Acquisition of Unique Pyrotechnic

ACCESS Newswire

S&P CORELOGIC CASE-SHILLER INDEX RECORDS 3.9% ANNUAL GAIN IN DECEMBER 2024

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors

Recce Pharmaceuticals Reports Positive Data from Phase II Trial of RECCE® 327 Gel in Acute Bacterial Skin and Skin Structure Infections, Supporting Accelerated Commercialization Pathway

Gladstone Investment Corp (GAIN) Q3 2025 Earnings Call Highlights: Record Capital Deployment ...

Here's What Key Metrics Tell Us About Gladstone Investment (GAIN) Q3 Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GAIN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GAIN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GAIN\",,,,,undefined,":{"symbol":"GAIN","market":"US","secType":"STK","nameCN":"Gladstone Investment","latestPrice":13.75,"timestamp":1746820800000,"preClose":13.73,"halted":0,"volume":61434,"hourTrading":{"tag":"盘后","latestPrice":13.88,"preClose":13.75,"latestTime":"18:35 EDT","volume":648,"amount":8911.100304,"timestamp":1746830120767},"delay":0,"floatShares":35789100,"shares":36837381,"eps":1.915896,"marketStatus":"Post-Mkt","change":0.02,"latestTime":"05-09 18:49:22 EDT","open":13.74,"high":13.8815,"low":13.7,"amount":846189.274338,"amplitude":0.013219,"askPrice":13.89,"askSize":500,"bidPrice":13.76,"bidSize":1,"shortable":3,"etf":0,"ttmEps":1.915896,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746835200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":13.73,"dividendRate":0.069818,"preHourTrading":{"tag":"盘前","latestPrice":13.92,"preClose":13.73,"latestTime":"09:17 EDT","volume":52,"amount":722.8699399999999,"timestamp":1746796655854},"postHourTrading":{"tag":"盘后","latestPrice":13.88,"preClose":13.75,"latestTime":"18:35 EDT","volume":648,"amount":8911.100304,"timestamp":1746830120767},"volumeRatio":0.639116,"impliedVol":0.2797,"impliedVolPercentile":0.424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GAIN\",,,,,undefined,":{"symbol":"GAIN","floatShares":35789100,"roa":"3.36%","roe":"14.74%","lyrEps":2.474995,"volumeRatio":0.639116,"shares":36837381,"dividePrice":0.96,"high":13.8815,"amplitude":0.013219,"preClose":13.73,"low":13.7,"week52Low":11.42,"pbRate":"1.03","psRate":"5.68","week52High":14.85,"institutionHeld":0.1403,"latestPrice":13.75,"committee":-0.996008,"eps":1.915896,"divideRate":0.069818,"volume":61434,"delay":0,"ttmEps":1.915896,"open":13.74,"prevYearClose":13.25,"prevWeekClose":13.99,"prevMonthClose":13.75,"prevQuarterClose":13.36,"fiveDayClose":13.99,"twentyDayClose":12.7,"sixtyDayClose":13.31,"earningDate":1747065600000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GAIN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531756035","title":"Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2531756035","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531756035?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012600,"startTime":"0","endTime":"0","summary":"David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:. International: Click here for participant international Toll-Free access numbers. Acurx previously announced that it had received positive regulatory guidance from the EMA during its Scientific Advice Procedure which confirmed that the clinical, non-clinical and CMC  information package submitted to EMA supports advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application  for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details on Acurx's two planned international Phase 3 clinical trials, 1:1 randomized , primary and secondary endpoints, sample size, statistical analysis plan and the overall registration sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-first-quarter-113000266.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-first-quarter-113000266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4194","BK4588","MAA","GAIN","BK4563","ACXP","BK4215","BK4135","VRE","BK4139","BK4585","BK4539"],"gpt_icon":0},{"id":"2531276926","title":"S&P CORELOGIC CASE-SHILLER INDEX RECORDS 3.9% ANNUAL GAIN IN FEBRUARY 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531276926","media":"PR Newswire","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531276926?lang=en_us&edition=fundamental","pubTime":"2025-04-30 00:48","pubTimestamp":1745945280,"startTime":"0","endTime":"0","summary":"The S&P CoreLogic Case-Shiller U.S. National Home Price NSA Index, covering all nine U.S. census divisions, reported a 3.9% annual return for February, down from a 4.1% annual gain in the previous month. The 10-City Composite saw an annual increase of 5.2%, down from a 5.4% annual increase in the previous month. The 20-City Composite posted a year-over-year increase of 4.5%, down from a 4.7% increase in the previous month. New York again reported the highest annual gain among the 20 cities with a 7.7% increase in February, followed by Chicago and Cleveland with annual increases of 7.0% and 6.6%, respectively. Tampa posted the lowest return, falling 1.5%. The pre-seasonally adjusted U.S. National, 10-City Composite, and 20-City Composite Indices presented slight upward trends in February, posting 0.4%, 0.8%, and 0.7% respectively.After seasonal adjustment, the 10-City and 20-City Composite Indices posted month-over-month increases of 0.5% and 0.4%. The U.S. National Composite Index post","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/p-corelogic-case-shiller-index-164800532.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/p-corelogic-case-shiller-index-164800532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999001077.SGD","LU1633808545.USD","BK4135","LU0158827781.USD","LU2089283258.USD","GAIN","LU0345774631.USD","LU1989764664.SGD","LU1363072403.SGD","LU2028103732.USD","GB00BDT5M118.USD","LU2264538146.SGD","LU2271345857.HKD","SPGI","LU2095319765.USD","LU2764263039.SGD","SG9999017495.SGD","SG9999018857.SGD","LU0868494617.USD","LU0354030438.USD","CLGX","LU1064131342.USD","BK4534","LU2210149790.SGD","LU0342679015.USD","NSA","LU1496350502.SGD","LU2764263203.CNY","BK4217","LU2111349929.HKD","BK4084","BK4581","SG9999014914.USD","LU1989772923.USD","LU2210150020.SGD","SG9999014906.USD","LU1989772840.SGD","IE00B19Z9505.USD","SG9999018865.SGD","LU1989773731.SGD","LU2023251221.USD","BK4112","BK4566","LU0971096721.USD","LU1989764748.USD","LU2089284900.SGD","LU2720916845.USD","BK4597","LU0345774391.USD"],"gpt_icon":0},{"id":"2530951986","title":"KIA EV6, EV9 AND NIRO OWNERS GAIN ACCESS TO OVER 21,500 TESLA SUPERCHARGERS","url":"https://stock-news.laohu8.com/highlight/detail?id=2530951986","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530951986?lang=en_us&edition=fundamental","pubTime":"2025-04-25 00:00","pubTimestamp":1745510400,"startTime":"0","endTime":"0","summary":"Available across the country, Tesla Supercharger network availability makes charging easier, faster and more convenient. Ever-growing network answers the call for greater access to fast-charging options. 2025 model yearKia EV6 and 2026 model year EV9 come standard with NACS charging ports. IRVINE, Calif., April 24, 2025 /PRNewswire/ -- Kia EV owners now have access to the more than 21,500 DC fast chargers within the Tesla Supercharger network. With more than 22,000 accessible DC fast chargers already online in other networks, Kia EV owners now can charge at more than 40,000 DC fast chargers, increasing convenience and reducing range anxiety. Kia EV customers that have Kia EVs with the standard NACS ports or Kia NACS adapters can now access the Tesla Supercharger network via the Kia Access1 app2. Additionally, customers can search, locate and navigate to available charging stations through their EV infotainment screen and on their compatible smart phone devices, including charger availa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/kia-ev6-ev9-niro-owners-160000203.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kia-ev6-ev9-niro-owners-160000203.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4516","BK4551","BK4588","LU0820561818.USD","LU2023250330.USD","BK4099","TSYW.SI","LU2360107168.USD","LU1674673691.USD","LU1720051017.SGD","LU2213496289.HKD","LU1066051498.USD","LU1066053197.SGD","IE00BWXC8680.SGD","LU1548497426.USD","BK4511","LU0820562030.AUD","BK4612","TSLA","LU2290526834.HKD","LU1674673428.USD","BK4604","LU1629891620.HKD","GAIN","LU2360106780.USD","LU0198837287.USD","LU0943347566.SGD","BK4574","TSLL","LU0323591593.USD","LU1914381329.SGD","LU0345770308.USD","LU1861215975.USD","LU2108987350.USD","LU0719512351.SGD","LU2250418816.HKD","LU2063271972.USD","IE00BJLML261.HKD","BK4550","LU0316494557.USD","LU0053666078.USD","LU1861220033.SGD","BK4581","IE0034235303.USD","LU1145028129.USD","BK4592","SG9999015945.SGD","SG9999015986.USD","LU0082616367.USD","KIMTF"],"gpt_icon":1},{"id":"2529507878","title":"Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2529507878","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529507878?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:00","pubTimestamp":1745409600,"startTime":"0","endTime":"0","summary":"Human Research Ethics Committee  approval received to allow up to 20 additional patients access to RECCE 327 Topical Gel  treatment under existing open-label study protocol. Program enables access to R327G for diabetic foot infections , following recent positive Phase II results in acute bacterial skin and skin-structure infections , including diabetic foot ulcers . Access focused on patients with DFU infections given the unmet medical need, as ~40% experience ulcer recurrence within a year of healing. The study will start now, running in parallel to Registrational Phase 3 in Indonesia for DFI and planned Registrational Phase 3 for ABSSSI in Australia, on track for H2 2025. The study will start now and run in parallel with Recce’s Indonesian Phase 3 trial, which remains on track to commence shortly. This program does not impact the initiation timeline of the Registrational Phase 3 DFI study in Indonesia or the planned Registrational Phase 3 ABSSSI study in Australia. The study is desig","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recce-pharmaceuticals-receives-approval-additional-120000639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["AU","LU0788108826.HKD","LU0055631609.USD","LU0498741890.SGD","BK4570","LU1223083913.SGD","LU0724618789.USD","XKO.AU","LU1223082519.USD","LU0368265764.SGD","LU0498741114.HKD","BK4017","XJO.AU","LU1223082196.USD","BK4533","XAO.AU","LU0345780521.USD","BK4585","BK4522","BK4135","RCE.AU","GAIN","BK4588","BK7096","LU0345780281.USD","LU0496367417.USD","USA"],"gpt_icon":0},{"id":"2526517385","title":"Gladstone Investment (GAIN) Moves 11.0% Higher: Will This Strength Last?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526517385","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526517385?lang=en_us&edition=fundamental","pubTime":"2025-04-10 22:45","pubTimestamp":1744296300,"startTime":"0","endTime":"0","summary":"Gladstone Investment  shares soared 11% in the last trading session to close at $13.06. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 10% loss over the past four weeks.Gladstone Investment shares rallied sharply, benefiting from broad market strength following President Donald Trump’s announcement of a 90-day suspension on tariffs for non-retaliating countries. The policy shift eased trade tensions and improved market sentiment, fueling a sharp uptick in GAIN shares.This business development company is expected to post quarterly earnings of $0.24 per share in its upcoming report, which represents no change from the year-ago quarter. Revenues are expected to be $24.57 million, up 3.9% from the year-ago quarter.Gladstone Investment Corporation  : Free Stock Analysis Report. Morgan Stanley Direct Lending Fund  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gladstone-investment-gain-moves-11-144500675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0971096721.USD","LU1732800096.USD","LU2089283258.USD","IE00BKVL7J92.USD","BK4581","LU1548497426.USD","LU2271345857.HKD","LU0106261372.USD","BK4127","LU2347655156.SGD","GAINI","LU0158827948.USD","LU2133065610.SGD","LU0006306889.USD","LU1074936037.SGD","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU2111349929.HKD","GAIN","LU1720051108.HKD","LU1732799900.SGD","LU1363072403.SGD","BK4534","LU0795875086.SGD","LU0314104364.USD","LU2357305700.SGD","LU0158827781.USD","BK4588","LU0795875169.SGD","LU1989772923.USD","LU1668664300.SGD","BK4504","LU2089284900.SGD","BK4135","BK4585","GAINZ","LU0106831901.USD","LU2023251221.USD","GAINL","MSDL","LU2028103732.USD","BK4516","LU0225283273.USD","LU0267386448.USD","LU1162221912.USD","LU0320765646.SGD","LU0912757837.SGD","LU0098860793.USD","LU1720051017.SGD"],"gpt_icon":0},{"id":"2526563494","title":"Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2526563494","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526563494?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:00","pubTimestamp":1744286400,"startTime":"0","endTime":"0","summary":"A$5.0 million commitment received from Australian-based private investorA$10.8 million Entitlement Offer at the same offer price as the placementFunds to support Phase III Topical clinical trials in I","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059191/0/en/Recce-Pharmaceuticals-Announces-A-5-0-million-Placement-Launches-A-10-8-million-Entitlement-Offer-to-Shareholders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA","LU0498741114.HKD","AU","TERP","BK4570","LU0496367417.USD","LU0345780281.USD","LU1223083913.SGD","BK4017","LU0368265764.SGD","LU1223082519.USD","LU0724618789.USD","LU0345780521.USD","LU0788108826.HKD","LU1223082196.USD","GAIN","BK4588","BK4585","BK4533","LU0498741890.SGD","LU0055631609.USD","BK4135","BK4522"],"gpt_icon":0},{"id":"2526823451","title":"Gladstone Investment Keeps Monthly Distributions; Declares Supplemental Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2526823451","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526823451?lang=en_us&edition=fundamental","pubTime":"2025-04-09 04:49","pubTimestamp":1744145380,"startTime":"0","endTime":"0","summary":"Gladstone Investment  said Tuesday it kept the monthly cash distributions for April, May and June at $0.08 a share.The cash distributions are payable on April 30, May 30 and June 30 to shareholders of record on April 21, May 21 and June 20, respectively.The company also declared a supplemental distribution of $0.54 a share, payable on June 13 to shareholders on June 4.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GAIN","GAINI","GAINL","GAINZ"],"gpt_icon":0},{"id":"2526882359","title":"Gladstone Investment Announces Monthly Cash Distributions for April, May and June 2025, a Supplemental Distribution to Common Stockholders, and Earnings Release and Conference Call Dates for the Fourth Fiscal Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2526882359","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526882359?lang=en_us&edition=fundamental","pubTime":"2025-04-09 04:05","pubTimestamp":1744142700,"startTime":"0","endTime":"0","summary":"MCLEAN, VA / ACCESS Newswire / April 8, 2025 / Gladstone Investment Corporation   announced today that its board of directors declared the following monthly cash distributions to common stockholders. The Company also announced its plan to report earnings for its fourth fiscal quarter ended March 31, 2025.Common Stock: $0.08 per share of common stock for each of April, May and June 2025, and a supplemental distribution of $0.54 per share of common stock in June 2025, all payable per the table below.The statements in this press release regarding potential future distributions, earnings and operations of the Company are \"forward-looking statements.\" These forward-looking statements inherently involve certain risks and uncertainties in predicting future results and conditions. Although these statements are based on the Company's current plans that are believed to be reasonable as of the date of this press release, a number of factors could cause actual results and conditions to differ mate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gladstone-investment-announces-monthly-cash-200500960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GAINI","GAIN","GAINL","GAINZ"],"gpt_icon":0},{"id":"2524475752","title":"42-Year-Old With $250K And A 'Failed Marriage, 3 Kids' Faces A Full Life Restart – 'How Would You Divide It Up?' Reddit Explodes With Advice","url":"https://stock-news.laohu8.com/highlight/detail?id=2524475752","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524475752?lang=en_us&edition=fundamental","pubTime":"2025-04-03 10:00","pubTimestamp":1743645630,"startTime":"0","endTime":"0","summary":"Life has a way of throwing curveballs, such as divorce, career changes, and financial setbacks, and sometimes, it feels like you're back at square one.But hitting the reset button in your 40s doesn't mean your financial future is doomed. In fact, with thorough planning and disciplined investing, it's possible to rebuild and even come out stronger than before.For one Redditor, a 42-year-old facing a divorce and raising three kids, rebuilding financially seems like a tough challenge, but also an opportunity for a fresh start. With $250,000 to invest and a stable business generating between $90,000 and $120,000 per year on average, the investor is determined to turn things around.Inspired by Uber and Airbnb – Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets – with $1,000 you can invest at just $0.26/share!This Jeff Bezos-backed startup will allow you to become a landlord in just 10 minutes, with minimum investments as low as $","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/42-old-250k-failed-marriage-020030633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPY","SDS","OEF","ESmain","BK4588",".SPX","BK4581","BK4504","LU1861220033.SGD","RDDT","SH","BK4585","MAIN","UPRO","BK4547","GAIN","LU2360107168.USD","BK4534","SPXU","VOO","FDN","LU2290526834.HKD","OEX","BK4550","LU1861215975.USD","BK4559","BK4077","IVV","SSO","BK4135"],"gpt_icon":1},{"id":"2518369708","title":"Gladstone Investment Corporation Exits Its Investment in Nocturne Luxury Villas","url":"https://stock-news.laohu8.com/highlight/detail?id=2518369708","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518369708?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:30","pubTimestamp":1741725000,"startTime":"0","endTime":"0","summary":"MCLEAN, VA / ACCESS Newswire / March 11, 2025 / Gladstone Investment Corporation   announced today the sale of its portfolio company Nocturne Luxury Villas, Inc.  to an affiliate of Calera Capital. As a result of this transaction, Gladstone Investment received full repayment of its debt investment and realized a significant capital gain on its equity investment. Gladstone Investment formed Nocturne in partnership with Aureus Capital, LLC  in 2021.Forward-looking Statements:The statements in this press release regarding the longer-term prospects of Gladstone Investment, Nocturne and its management team, and the ability of Gladstone Investment and Nocturne to grow and expand are \"forward-looking statements.\" These forward-looking statements inherently involve certain risks and uncertainties in predicting future results and conditions. Although these statements are based on Gladstone Investment's current plans that are believed to be reasonable as of the date of this press release, a numb","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gladstone-investment-corporation-exits-investment-203000184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GAIN","GAINI","GAINL","GAINZ","BK4135"],"gpt_icon":0},{"id":"2516635992","title":"Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2516635992","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516635992?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat  to other anti-CDI antibiotics in a germ-free mouse model. Changes in alpha and beta microbiome diversities following IBZ treatment were less pronounced compared to those observed in vancomycin -or metronidazole -treated groups, complementing prior Phase 2 clinical findings showing IBZ's more selective antibacterial activity. Notable differences were observed between the microbiome of IBZ- and fidaxomicin -treated groups, which may allow for differentiation of these two anti-CDI antibiotics in future studies. Results establish IBZ differentiating effects on the gut microbiome, indicating a more selective spectrum of microbiome alteration compared to broader-spectrum antibiotics like VAN and MET and a narrower spectrum of microbiome alteration compared to FDX. Preparation continues to advance IBZ into international Ph3 clinical trials for treatment of CDI. IBZ has previously been granted FDA QIDP a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-announces-publication-nonclinical-vivo-130000861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4215","BK4202","LU0310800965.SGD","LU0048573561.USD","LU1571399168.USD","BK4218","BK4585","LU1989772923.USD","LU1267930227.SGD","ECC","LU0052756011.USD","LU0251142724.SGD","NCI","BK4135","LU0251131958.USD","BK4131","MAA","BK4181","VRE","LU1496350502.SGD","LU0128525689.USD","BK4539","LU0742534661.SGD","LU1989771016.USD","MET","LU1989772840.SGD","PK","FDX","BK4162","GAIN","LU1291159041.SGD","BK4563","BK4139","ACXP","BK4533","BK4194","BK4588","IDSA"],"gpt_icon":0},{"id":"2514321656","title":"Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321656","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514321656?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:. Click here for participant international Toll-Free access numbers. Acurx previously announced that it had received positive regulatory guidance from the EMA during its Scientific Advice Procedure which confirmed that the clinical, non-clinical and CMC  information package submitted to EMA supports advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application  for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details on Acurx's two planned international Phase 3 clinical trials, 1:1 randomized , primary and secondary endpoints, sample size, statistical analysis plan and the overall registration safety database. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-fourth-quarter-130000228.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-fourth-quarter-130000228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACXP","BK4139","BK4563","BK4194","BK4539","BK4135","GAIN","VRE","BK4215","BK4585","MAA","BK4588"],"gpt_icon":0},{"id":"2514804644","title":"Recce Pharmaceuticals Granted Japanese Patent for RECCE® Anti-Infectives","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804644","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514804644?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":"SYDNEY, Feb.  27, 2025  (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company) the Company developing a new class of synthetic anti-infectives, today announced it w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033826/0/en/Recce-Pharmaceuticals-Granted-Japanese-Patent-for-RECCE-Anti-Infectives.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0498741890.SGD","LU0724618789.USD","BK4017","LU0368265764.SGD","LU1223082519.USD","BK4570","BK4588","BK4135","BK4090","BK4585","BK4522","LU1223082196.USD","BK4533","LU0055631609.USD","PCT","LU0496367417.USD","GAIN","AU","LU0498741114.HKD","LU0788108826.HKD","LU1223083913.SGD","USA"],"gpt_icon":0},{"id":"2514611895","title":"Gladstone Investment Corporation Expands its Investment in Pyrotek Special Effects via the Acquisition of Unique Pyrotechnic","url":"https://stock-news.laohu8.com/highlight/detail?id=2514611895","media":"ACCESS Newswire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514611895?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:30","pubTimestamp":1740605400,"startTime":"0","endTime":"0","summary":"MCLEAN, VA / ACCESS Newswire / February 26, 2025 / Gladstone Investment Corporation   continued its support of portfolio company Pyrotek Special Effects, Inc.  through providing additional capital to support the acquisition of Unique Pyrotechnic .Unique designs and delivers live special effects solutions in Sweden, Norway, and Denmark. Pyrotek is a leading provider of special effects services and solutions for the live entertainment industry with a full range of special effects offerings, creative and technical design services, permitting and logistics support worldwide, and specialized installation, setup, and tear down. \"Pyrotek is excited to welcome the team at Unique Pyrotechnic to the Pyrotek group. Through this business combination, we are thrilled to now offer our clients truly global solutions and an expanded reach with a network of offices in Las Vegas, Nashville, Lititz, Toronto, New York, Copenhagen, Oslo, and Gothenburg,\" said Scott Dunlop, CEO of Pyrotek.Erika Highland, Se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gladstone-investment-corporation-expands-investment-213000253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GAINI","GAIN","BK4135","GAINL","GAINZ"],"gpt_icon":0},{"id":"2514015597","title":"S&P CORELOGIC CASE-SHILLER INDEX RECORDS 3.9% ANNUAL GAIN IN DECEMBER 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015597","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514015597?lang=en_us&edition=fundamental","pubTime":"2025-02-25 23:00","pubTimestamp":1740495600,"startTime":"0","endTime":"0","summary":"The S&P CoreLogic Case-Shiller U.S. National Home Price NSA Index, covering all nine U.S. census divisions, reported a 3.9% annual return for December, up from a 3.7% annual gain in the previous month. The 10-City Composite saw an annual increase of 5.1%, up from a 5% annual increase in the previous month. The 20-City Composite posted a year-over-year increase of 4.5%, up from a 4.3% increase in the previous month. New York again reported the highest annual gain among the 20 cities with a 7.2% increase in December, followed by Chicago and Boston with annual increases of 6.6% and 6.3%, respectively. Tampa posted the lowest return, falling 1.1%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/p-corelogic-case-shiller-index-150000225.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/p-corelogic-case-shiller-index-150000225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0985320562.USD","LU2720916845.USD","GB00BDT5M118.USD","SG9999001077.SGD","LU1989764748.USD","BK4135","LU1989772840.SGD","NSA","BK4548","SG9999017495.SGD","LU0971096721.USD","LU1989764664.SGD","LU0342679015.USD","LU2111349929.HKD","BK4534","LU0097036916.USD","LU0158827781.USD","BK4566","LU1988902786.USD","LU2028103732.USD","GAIN","LU1989773731.SGD","CLGX","SGXZ31699556.SGD","LU0158827948.USD","LU0154236417.USD","BK4084","SG9999018857.SGD","LU0354030438.USD","LU0345774391.USD","SPGI","LU1496350171.SGD","BK4588","BK4017","LU0868494617.USD","LU1363072403.SGD","IE00B19Z9505.USD","SG9999018865.SGD","LU2210150020.SGD","LU2764263203.CNY","LU2264538146.SGD","LU1804176565.USD","SG9999014906.USD","LU1989772923.USD","BK4597","SG9999014880.SGD","LU1064131342.USD","LU2265009873.SGD","LU2764262908.HKD"],"gpt_icon":0},{"id":"2513726852","title":"Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726852","media":"CNW Group","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726852?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:00","pubTimestamp":1740402000,"startTime":"0","endTime":"0","summary":"Major finding provides mechanistic explanation for ibezapolstat's  selectivity in that the predicted bactericidal interaction between IBZ and its target DNA pol IIIC is conserved across most of the Bacillota phylum, including C. difficile, while certain beneficial taxa are naturally resistant to IBZ, allowing regrowth of resistant microbes known to confer health benefits. This study used in silico methods to better interpret the narrower than expected ibezapolstat  spectrum of activity observed in human trials, which included increased proportion of certain key gut microbiota of the Bacillota phylum. IBZ susceptibility of human commensal  microbiota was predicted using genomic analysis and a phylogenetic tree construction of the IBZ target enzyme, pol IIIC. Preparation continues to advance IBZ into international Ph3 clinical trials for treatment of CDI. IBZ has previously been granted FDA QIDP and Fast-Track Designation and has received SME  designation by the EMA. Acurx's Executive Ch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-announces-publication-positive-results-130000638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GAIN","BK4135","IDSA","ACXP","PK","BK4563","BK4539","BK4215","BK4218","BK4585","BK4139","MAA","VRE","BK4181","BK4588","ECC","BK4194"],"gpt_icon":0},{"id":"2512104227","title":"JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2512104227","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512104227?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"STATEN ISLAND, N.Y., Feb. 19, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc.  , a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that a new patent has been granted by the Japanese Patent Office  in January 2025. This patent relates to DNA Polymerase IIIC Inhibitors, including compositions-of-matter, surface coatings and pharmaceutical compositions for use in methods of treatingGram-positive bacterial infection. This is the latest in the series of granted patents and pending patent applications that Acrux has filed to protect its proprietary technologies in the field of antimicrobials.To date, Acurx has obtained three U.S. patents, one Israeli patent and now one Japanese patent, in each case, which cover the ACX-375C program, relating to DNA Polymerase IIIC Inhibitors, with other country-level filings in process.The primary efficacy analysis will be performed using a Modified Intent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jpo-grants-acurx-pharmaceuticals-patent-130000150.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jpo-grants-acurx-pharmaceuticals-patent-130000150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VRE","PK","BK4585","BK4194","DNA","IDSA","BK4139","BK4539","GAIN","BK4109","BK4218","BK4563","MAA","BK4215","ECC","ACXP","BK4588","BK4181","BK4135"],"gpt_icon":0},{"id":"2512064101","title":"Recce Pharmaceuticals Reports Positive Data from Phase II Trial of RECCE® 327 Gel in Acute Bacterial Skin and Skin Structure Infections, Supporting Accelerated Commercialization Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2512064101","media":"GlobeNewswire","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512064101?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"Phase II trial assessed the efficacy and safety of RECCE 327 topical gel in patients with acute bacterial skin and skin structure infections (ABSSSI), including those with diabetic foot infections (DF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/19/3028726/0/en/Recce-Pharmaceuticals-Reports-Positive-Data-from-Phase-II-Trial-of-RECCE-327-Gel-in-Acute-Bacterial-Skin-and-Skin-Structure-Infections-Supporting-Accelerated-Commercialization-Path.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0498741890.SGD","BK4570","GAIN","BK4017","LU1223082196.USD","BK4533","LU0496367417.USD","BK4522","AU","USA","LU0788108826.HKD","AMR","LU0368265764.SGD","LU0498741114.HKD","BK4006","LU0055631609.USD","BK4135","LU1223082519.USD","BK4585","BK4588","LU0724618789.USD","LU1223083913.SGD"],"gpt_icon":0},{"id":"2511630301","title":"Gladstone Investment Corp (GAIN) Q3 2025 Earnings Call Highlights: Record Capital Deployment ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2511630301","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511630301?lang=en_us&edition=fundamental","pubTime":"2025-02-14 15:12","pubTimestamp":1739517125,"startTime":"0","endTime":"0","summary":"Adjusted Net Investment Income : $0.23 per share.Total Assets: Approximately $1.1 billion, up from $869 million in the prior quarter.New Capital Deployed: Over $187 million, marking the largest investment quarter.Monthly Distribution: $0.08 per share, or $0.96 per share annually.Supplemental Distribution: $0.70 per share paid during the quarter.Total Investment Income: $21.4 million, down from $22.6 million in the prior quarter.Net Expenses: $20.2 million, up from $15.3 million in the prior quarter.Net Asset Value : Increased to $13.30 per share from $12.49 per share in the prior quarter.New Publicly Traded Notes Issued: $126.5 million in 7.875% notes maturing in 2030.Credit Facility Upsized: Total commitment levels increased to $250 million.Asset Coverage Ratio: 185.9% as of December 31, 2024.GuruFocus has detected 7 Warning Sign with GAIN.Gladstone Investment Corp  reported consistent positive quarterly results with an increase in total assets to approximately $1.1 billion, up from $","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gladstone-investment-corp-gain-q3-071205930.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GAINI","GAINL","GAINZ","GAIN"],"gpt_icon":0},{"id":"2511355316","title":"Here's What Key Metrics Tell Us About Gladstone Investment (GAIN) Q3 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2511355316","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511355316?lang=en_us&edition=fundamental","pubTime":"2025-02-13 07:30","pubTimestamp":1739403012,"startTime":"0","endTime":"0","summary":"For the quarter ended December 2024, Gladstone Investment  reported revenue of $21.37 million, down 7.4% over the same period last year. EPS came in at $0.23, compared to $0.26 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $23.08 million, representing a surprise of -7.41%. The company delivered an EPS surprise of -4.17%, with the consensus EPS estimate being $0.24.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Gladstone Investment performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-key-metrics-tell-us-233012799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GAIN","GAINL","GAINZ","GAINI"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GAIN\",params:#limit:5,,,undefined,":[{"date":"2025-06-20","symbol":"GAIN","amount":0.08,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-20","defaultRemindTime":1750426200000,"name":"格拉德斯通投资","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-20","currency":"USD","dateTimestamp":1750392000000,"payDate":"2025-06-30"},{"date":"2025-06-04","symbol":"GAIN","amount":0.54,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-04","defaultRemindTime":1749043800000,"name":"格拉德斯通投资","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-13","payableDate":"2025-06-04","currency":"USD","dateTimestamp":1749009600000,"payDate":"2025-06-13"},{"date":"2025-05-21","symbol":"GAIN","amount":0.08,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-21","defaultRemindTime":1747834200000,"name":"格拉德斯通投资","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-30","payableDate":"2025-05-21","currency":"USD","dateTimestamp":1747800000000,"payDate":"2025-05-30"},{"date":"2025-05-13","symbol":"GAIN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.23,"defaultRemindTime":1747166400000,"name":null,"time":"Post Market","dateTimestamp":1747108800000,"actualEps":null},{"date":"2025-04-21","symbol":"GAIN","amount":0.08,"announcedDate":"2025-04-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-21","defaultRemindTime":1745242200000,"name":"格拉德斯通投资","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-30","payableDate":"2025-04-21","currency":"USD","dateTimestamp":1745208000000,"payDate":"2025-04-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GAIN\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-15","recordDate":"2015-05-19","paymentDate":"2015-05-29","value":0.0625,"currency":"USD"},{"executeDate":"2015-06-17","recordDate":"2015-06-19","paymentDate":"2015-06-30","value":0.0625,"currency":"USD"},{"executeDate":"2015-07-22","recordDate":"2015-07-24","paymentDate":"2015-08-04","value":0.0625,"currency":"USD"},{"executeDate":"2015-08-18","recordDate":"2015-08-20","paymentDate":"2015-08-31","value":0.0625,"currency":"USD"},{"executeDate":"2015-09-17","recordDate":"2015-09-21","paymentDate":"2015-09-30","value":0.0625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GAIN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.1667,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.1667,"analysts":6,"updateTime":1744948800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GAIN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GAIN","date":"2025-05-08","current":7.243335,"percent":0.605519,"low":-52.128058,"twenty":-16.980463,"median":6.493289,"eighty":10.895978,"high":14.419672,"avg":0.742583,"sd":15.67817,"marketCap":507250736},"quantilePoints":[{"date":"2020-05-15","current":-47.011194,"twenty":4.060803,"median":7.701567,"eighty":12.106757,"marketCap":340078974},{"date":"2020-05-22","current":-49.067077,"twenty":4.04127,"median":7.662509,"eighty":12.070236,"marketCap":354951232},{"date":"2020-05-29","current":-50.666097,"twenty":4.031751,"median":7.639199,"eighty":12.006324,"marketCap":366518544},{"date":"2020-06-05","current":-50.848842,"twenty":4.022067,"median":7.601255,"eighty":11.545532,"marketCap":367840523},{"date":"2020-06-12","current":-49.02139,"twenty":4.009155,"median":7.590527,"eighty":10.960693,"marketCap":354620737},{"date":"2020-06-19","current":-49.140074,"twenty":3.999472,"median":7.557729,"eighty":10.597689,"marketCap":355479294},{"date":"2020-06-26","current":-46.295364,"twenty":3.993016,"median":7.506236,"eighty":10.433041,"marketCap":334900660},{"date":"2020-07-02","current":-46.203599,"twenty":3.98656,"median":7.471824,"eighty":10.336693,"marketCap":334236834},{"date":"2020-07-10","current":-44.299478,"twenty":3.983261,"median":7.434691,"eighty":10.25411,"marketCap":320462426},{"date":"2020-07-17","current":-45.675951,"twenty":3.967792,"median":7.408799,"eighty":10.088943,"marketCap":330419829},{"date":"2020-07-24","current":-46.341246,"twenty":3.951052,"median":7.3849,"eighty":10.029109,"marketCap":335232574},{"date":"2020-07-31","current":-23.096312,"twenty":3.909088,"median":7.368967,"eighty":9.89442,"marketCap":305818261},{"date":"2020-08-07","current":-23.898789,"twenty":3.88972,"median":7.353034,"eighty":9.854957,"marketCap":316443869},{"date":"2020-08-14","current":-24.488109,"twenty":3.880036,"median":7.342249,"eighty":9.832256,"marketCap":324247049},{"date":"2020-08-21","current":-23.785941,"twenty":3.867244,"median":7.337101,"eighty":9.799901,"marketCap":314949643},{"date":"2020-08-28","current":-23.547705,"twenty":3.860668,"median":7.280787,"eighty":9.780453,"marketCap":311795165},{"date":"2020-09-04","current":-23.146466,"twenty":3.838072,"median":7.11953,"eighty":9.772373,"marketCap":306482362},{"date":"2020-09-11","current":-23.021079,"twenty":3.809021,"median":7.056107,"eighty":9.758609,"marketCap":304822111},{"date":"2020-09-18","current":-23.296931,"twenty":3.792881,"median":7.022378,"eighty":9.740597,"marketCap":308474663},{"date":"2020-09-25","current":-22.745228,"twenty":3.786425,"median":6.985276,"eighty":9.731081,"marketCap":301169558},{"date":"2020-10-02","current":-22.82046,"twenty":3.773513,"median":6.948174,"eighty":9.72043,"marketCap":302165709},{"date":"2020-10-09","current":-22.996002,"twenty":3.767057,"median":6.917818,"eighty":9.703554,"marketCap":304490060},{"date":"2020-10-16","current":-22.569686,"twenty":3.754145,"median":6.826749,"eighty":9.68979,"marketCap":298845207},{"date":"2020-10-23","current":-22.143369,"twenty":3.744461,"median":6.79302,"eighty":9.676026,"marketCap":293200353},{"date":"2020-10-30","current":-20.889498,"twenty":3.738005,"median":6.76941,"eighty":9.662262,"marketCap":276597841},{"date":"2020-11-06","current":-16.776878,"twenty":3.728321,"median":6.559698,"eighty":9.656125,"marketCap":295524704},{"date":"2020-11-13","current":-17.77595,"twenty":3.718637,"median":6.479363,"eighty":9.640965,"marketCap":313123366},{"date":"2020-11-20","current":-18.134108,"twenty":3.715409,"median":6.446911,"eighty":9.634734,"marketCap":319432321},{"date":"2020-11-27","current":-18.925826,"twenty":3.712181,"median":6.427981,"eighty":9.634734,"marketCap":333378430},{"date":"2020-12-04","current":-19.378237,"twenty":3.696041,"median":6.41446,"eighty":9.629679,"marketCap":341347636},{"date":"2020-12-11","current":-19.038929,"twenty":3.683129,"median":6.383361,"eighty":9.62097,"marketCap":335370732},{"date":"2020-12-18","current":-19.774095,"twenty":3.663761,"median":6.357672,"eighty":9.62097,"marketCap":348320691},{"date":"2020-12-24","current":-19.038929,"twenty":3.657305,"median":6.342601,"eighty":9.607206,"marketCap":335370732},{"date":"2020-12-31","current":-19.020078,"twenty":3.650849,"median":6.308995,"eighty":9.593442,"marketCap":335038682},{"date":"2021-01-08","current":-19.755245,"twenty":3.637937,"median":6.227868,"eighty":9.549012,"marketCap":347988641},{"date":"2021-01-15","current":-20.075702,"twenty":3.631481,"median":6.1846,"eighty":9.538928,"marketCap":353633494},{"date":"2021-01-22","current":-20.339608,"twenty":3.628253,"median":6.173783,"eighty":9.527542,"marketCap":358282198},{"date":"2021-01-29","current":-19.283984,"twenty":3.612114,"median":6.0107,"eighty":9.486297,"marketCap":339687385},{"date":"2021-02-05","current":-24.699177,"twenty":3.592746,"median":5.917424,"eighty":9.414512,"marketCap":386838517},{"date":"2021-02-12","current":-25.314007,"twenty":3.53787,"median":5.870541,"eighty":9.414119,"marketCap":396467974},{"date":"2021-02-19","current":-25.186801,"twenty":3.42489,"median":5.820489,"eighty":9.414119,"marketCap":394475673},{"date":"2021-02-26","current":-25.1656,"twenty":3.418435,"median":5.788959,"eighty":9.414119,"marketCap":394143623},{"date":"2021-03-05","current":-25.547218,"twenty":3.341609,"median":5.760028,"eighty":9.394946,"marketCap":400120527},{"date":"2021-03-12","current":-26.331655,"twenty":3.258972,"median":5.733237,"eighty":9.37422,"marketCap":412406385},{"date":"2021-03-19","current":-25.907635,"twenty":3.20797,"median":5.70698,"eighty":9.347155,"marketCap":405765381},{"date":"2021-03-26","current":-26.01364,"twenty":3.192476,"median":5.690556,"eighty":9.331928,"marketCap":407425632},{"date":"2021-04-01","current":-26.543665,"twenty":3.18602,"median":5.662911,"eighty":9.304795,"marketCap":415726887},{"date":"2021-04-09","current":-28.430555,"twenty":3.172462,"median":5.64392,"eighty":9.2786,"marketCap":445279358},{"date":"2021-04-16","current":-29.829822,"twenty":3.131144,"median":5.626074,"eighty":9.203347,"marketCap":467194673},{"date":"2021-04-23","current":-29.745018,"twenty":3.036886,"median":5.612679,"eighty":9.074213,"marketCap":465866472},{"date":"2021-04-30","current":-30.169038,"twenty":3.004607,"median":5.606083,"eighty":8.970721,"marketCap":472507477},{"date":"2021-05-07","current":-29.278596,"twenty":2.852891,"median":5.587165,"eighty":8.912712,"marketCap":458561367},{"date":"2021-05-14","current":10.488514,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":445279358},{"date":"2021-05-21","current":10.74662,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":456237016},{"date":"2021-05-28","current":11.012548,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":467526723},{"date":"2021-06-04","current":11.419262,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":484793335},{"date":"2021-06-11","current":11.560047,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":490770239},{"date":"2021-06-18","current":10.871763,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":461549819},{"date":"2021-06-25","current":11.294119,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":479480532},{"date":"2021-07-02","current":11.528761,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":489442039},{"date":"2021-07-09","current":11.395797,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":483797185},{"date":"2021-07-16","current":11.294119,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":479480532},{"date":"2021-07-23","current":11.153334,"twenty":-0.957275,"median":5.587165,"eighty":8.90634,"marketCap":473503627},{"date":"2021-07-30","current":11.247191,"twenty":2.837397,"median":5.587165,"eighty":8.912712,"marketCap":477488230},{"date":"2021-08-06","current":5.431958,"twenty":2.837397,"median":5.587165,"eighty":8.912712,"marketCap":486453586},{"date":"2021-08-13","current":5.609934,"twenty":2.837397,"median":5.590318,"eighty":8.912712,"marketCap":502391997},{"date":"2021-08-20","current":5.339263,"twenty":2.837397,"median":5.584012,"eighty":8.912712,"marketCap":478152331},{"date":"2021-08-27","current":5.509822,"twenty":2.841271,"median":5.554316,"eighty":8.911119,"marketCap":493426641},{"date":"2021-09-03","current":5.51353,"twenty":2.841271,"median":5.543023,"eighty":8.911119,"marketCap":493758692},{"date":"2021-09-10","current":5.339263,"twenty":2.841271,"median":5.530411,"eighty":8.911119,"marketCap":478152331},{"date":"2021-09-17","current":5.291061,"twenty":2.841271,"median":5.518911,"eighty":8.911119,"marketCap":473835678},{"date":"2021-09-24","current":5.198365,"twenty":2.841271,"median":5.505186,"eighty":8.911119,"marketCap":465534422},{"date":"2021-10-01","current":5.194658,"twenty":2.841271,"median":5.479962,"eighty":8.911119,"marketCap":465202372},{"date":"2021-10-08","current":5.228028,"twenty":2.841271,"median":5.454205,"eighty":8.911119,"marketCap":468190824},{"date":"2021-10-15","current":5.454205,"twenty":2.841271,"median":5.451934,"eighty":8.911119,"marketCap":488445888},{"date":"2021-10-22","current":5.643304,"twenty":2.841271,"median":5.451934,"eighty":8.911119,"marketCap":505380450},{"date":"2021-10-29","current":5.876897,"twenty":2.841271,"median":5.451934,"eighty":8.911119,"marketCap":526299614},{"date":"2021-11-05","current":4.900371,"twenty":2.841271,"median":5.451934,"eighty":8.911119,"marketCap":544230326},{"date":"2021-11-12","current":4.942229,"twenty":2.841271,"median":5.451934,"eighty":8.911119,"marketCap":548879030},{"date":"2021-11-19","current":5.025945,"twenty":2.841271,"median":5.451934,"eighty":8.911119,"marketCap":558176436},{"date":"2021-11-26","current":5.019965,"twenty":2.841271,"median":5.451934,"eighty":8.911119,"marketCap":557512336},{"date":"2021-12-03","current":4.9213,"twenty":2.841271,"median":5.418445,"eighty":8.911119,"marketCap":546554678},{"date":"2021-12-10","current":4.957178,"twenty":2.841271,"median":5.39488,"eighty":8.911119,"marketCap":550539281},{"date":"2021-12-17","current":4.91831,"twenty":2.841271,"median":5.376341,"eighty":8.911119,"marketCap":546222628},{"date":"2021-12-23","current":4.954189,"twenty":2.841271,"median":5.339263,"eighty":8.911119,"marketCap":550207231},{"date":"2021-12-31","current":5.106671,"twenty":2.841271,"median":5.291061,"eighty":8.911119,"marketCap":567141792},{"date":"2022-01-07","current":5.052854,"twenty":2.845144,"median":5.248421,"eighty":8.909526,"marketCap":561164888},{"date":"2022-01-14","current":4.852534,"twenty":2.845144,"median":5.220612,"eighty":8.909526,"marketCap":538917523},{"date":"2022-01-21","current":4.628294,"twenty":2.845144,"median":5.194658,"eighty":8.909526,"marketCap":514013756},{"date":"2022-01-28","current":4.604376,"twenty":2.849018,"median":5.142748,"eighty":8.907933,"marketCap":511357354},{"date":"2022-02-04","current":4.685102,"twenty":2.849018,"median":5.067803,"eighty":8.907933,"marketCap":520322710},{"date":"2022-02-11","current":4.921279,"twenty":2.852891,"median":5.04239,"eighty":8.893091,"marketCap":522315011},{"date":"2022-02-18","current":4.764849,"twenty":2.852891,"median":5.019965,"eighty":8.893091,"marketCap":505712500},{"date":"2022-02-25","current":4.71792,"twenty":2.852891,"median":5.008006,"eighty":8.893091,"marketCap":500731746},{"date":"2022-03-04","current":4.664734,"twenty":2.852891,"median":4.973297,"eighty":8.892004,"marketCap":495086892},{"date":"2022-03-11","current":4.577133,"twenty":2.852891,"median":4.954189,"eighty":8.892004,"marketCap":485789486},{"date":"2022-03-18","current":4.911893,"twenty":2.852891,"median":4.947328,"eighty":8.892004,"marketCap":521318861},{"date":"2022-03-25","current":5.058937,"twenty":2.852891,"median":4.947328,"eighty":8.892004,"marketCap":536925221},{"date":"2022-04-01","current":5.105866,"twenty":2.852891,"median":4.947328,"eighty":8.892004,"marketCap":541905975},{"date":"2022-04-08","current":5.043294,"twenty":2.852891,"median":4.947328,"eighty":8.892004,"marketCap":535264970},{"date":"2022-04-14","current":5.058937,"twenty":2.852891,"median":4.944199,"eighty":8.882446,"marketCap":536925221},{"date":"2022-04-22","current":5.05268,"twenty":2.852891,"median":4.944199,"eighty":8.834656,"marketCap":536261121},{"date":"2022-04-29","current":4.861836,"twenty":2.852891,"median":4.942229,"eighty":8.801204,"marketCap":516006057},{"date":"2022-05-06","current":4.921279,"twenty":2.852891,"median":4.93326,"eighty":8.74545,"marketCap":522315011},{"date":"2022-05-13","current":4.728461,"twenty":2.852891,"median":4.9213,"eighty":8.722055,"marketCap":483797185},{"date":"2022-05-20","current":4.741442,"twenty":2.852891,"median":4.916666,"eighty":8.674137,"marketCap":485125386},{"date":"2022-05-27","current":4.929672,"twenty":2.852891,"median":4.901866,"eighty":8.641906,"marketCap":504384299},{"date":"2022-06-03","current":4.799858,"twenty":2.852891,"median":4.900371,"eighty":8.625976,"marketCap":491102290},{"date":"2022-06-10","current":4.681403,"twenty":2.852891,"median":4.890836,"eighty":8.587019,"marketCap":478982456},{"date":"2022-06-17","current":4.254641,"twenty":2.852891,"median":4.875331,"eighty":8.559532,"marketCap":435317851},{"date":"2022-06-24","current":4.488306,"twenty":2.849018,"median":4.843064,"eighty":8.513097,"marketCap":459225468},{"date":"2022-07-01","current":4.702498,"twenty":2.849018,"median":4.838802,"eighty":8.353786,"marketCap":481140783},{"date":"2022-07-08","current":4.757669,"twenty":2.849018,"median":4.809594,"eighty":8.175805,"marketCap":486785637},{"date":"2022-07-15","current":4.67329,"twenty":2.849018,"median":4.767978,"eighty":8.068421,"marketCap":478152331},{"date":"2022-07-22","current":4.725215,"twenty":2.849018,"median":4.760914,"eighty":7.903396,"marketCap":483465134},{"date":"2022-07-29","current":4.799858,"twenty":2.849018,"median":4.759848,"eighty":7.818777,"marketCap":491102290},{"date":"2022-08-05","current":7.400631,"twenty":2.849018,"median":4.759848,"eighty":7.805529,"marketCap":497411244},{"date":"2022-08-12","current":7.781038,"twenty":2.849018,"median":4.759848,"eighty":7.800749,"marketCap":522979112},{"date":"2022-08-19","current":7.583424,"twenty":2.849018,"median":4.759848,"eighty":7.800749,"marketCap":509697103},{"date":"2022-08-26","current":7.198078,"twenty":2.849018,"median":4.759848,"eighty":7.800749,"marketCap":483797185},{"date":"2022-09-02","current":6.94118,"twenty":2.849018,"median":4.759848,"eighty":7.800749,"marketCap":466530573},{"date":"2022-09-09","current":7.054808,"twenty":2.849018,"median":4.759848,"eighty":7.800749,"marketCap":474167728},{"date":"2022-09-16","current":6.94118,"twenty":2.849018,"median":4.759848,"eighty":7.800749,"marketCap":466530573},{"date":"2022-09-23","current":6.335988,"twenty":2.849018,"median":4.759848,"eighty":7.800749,"marketCap":425854419},{"date":"2022-09-30","current":5.977813,"twenty":2.849018,"median":4.759848,"eighty":7.800749,"marketCap":401780778},{"date":"2022-10-07","current":5.967932,"twenty":2.849018,"median":4.759848,"eighty":7.800749,"marketCap":401116677},{"date":"2022-10-14","current":6.042038,"twenty":2.849018,"median":4.759848,"eighty":7.787014,"marketCap":406097431},{"date":"2022-10-21","current":6.096381,"twenty":2.849018,"median":4.759848,"eighty":7.715021,"marketCap":409749983},{"date":"2022-10-28","current":6.447146,"twenty":2.849018,"median":4.759848,"eighty":7.644178,"marketCap":433325550},{"date":"2022-11-04","current":10.990966,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":463291202},{"date":"2022-11-11","current":11.093464,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":467611708},{"date":"2022-11-18","current":10.959428,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":461961815},{"date":"2022-11-25","current":11.266923,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":474923334},{"date":"2022-12-02","current":11.077695,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":466947015},{"date":"2022-12-09","current":10.62828,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":448003257},{"date":"2022-12-16","current":10.32867,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":435374085},{"date":"2022-12-23","current":10.123673,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":426733072},{"date":"2022-12-30","current":10.178865,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":429059499},{"date":"2023-01-06","current":10.218287,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":430721232},{"date":"2023-01-13","current":10.833276,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":456644269},{"date":"2023-01-20","current":10.612511,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":447338563},{"date":"2023-01-27","current":10.770201,"twenty":2.849018,"median":4.759848,"eighty":7.616938,"marketCap":453985496},{"date":"2023-02-03","current":9.849981,"twenty":2.849018,"median":4.759848,"eighty":7.652884,"marketCap":468711344},{"date":"2023-02-10","current":9.885134,"twenty":2.849018,"median":4.759848,"eighty":7.768985,"marketCap":470384119},{"date":"2023-02-17","current":9.899196,"twenty":2.849018,"median":4.759848,"eighty":7.903396,"marketCap":471053228},{"date":"2023-02-24","current":9.772644,"twenty":2.849018,"median":4.759848,"eighty":8.516468,"marketCap":465031241},{"date":"2023-03-03","current":9.639061,"twenty":2.849018,"median":4.759848,"eighty":9.327176,"marketCap":458674699},{"date":"2023-03-10","current":8.774287,"twenty":2.849018,"median":4.759848,"eighty":9.585392,"marketCap":417524452},{"date":"2023-03-17","current":8.992238,"twenty":2.849018,"median":4.759848,"eighty":9.585392,"marketCap":427895653},{"date":"2023-03-24","current":9.11879,"twenty":2.849018,"median":4.759848,"eighty":9.585392,"marketCap":433917640},{"date":"2023-03-31","current":9.315649,"twenty":2.852891,"median":4.759848,"eighty":9.583908,"marketCap":443285176},{"date":"2023-04-06","current":9.153944,"twenty":2.852891,"median":4.759848,"eighty":9.583908,"marketCap":435590414},{"date":"2023-04-14","current":9.540631,"twenty":2.849018,"median":4.759848,"eighty":9.585392,"marketCap":453990931},{"date":"2023-04-21","current":9.371895,"twenty":2.849018,"median":4.759848,"eighty":9.606719,"marketCap":445961615},{"date":"2023-04-28","current":9.547662,"twenty":2.849018,"median":4.759848,"eighty":9.606719,"marketCap":454325486},{"date":"2023-05-05","current":9.238312,"twenty":2.849018,"median":4.759848,"eighty":9.626871,"marketCap":439605072},{"date":"2023-05-12","current":9.085272,"twenty":2.849018,"median":4.759848,"eighty":9.626871,"marketCap":432322669},{"date":"2023-05-19","current":12.360449,"twenty":2.849018,"median":4.759848,"eighty":9.6939,"marketCap":439376885},{"date":"2023-05-26","current":12.095852,"twenty":2.849018,"median":4.759848,"eighty":9.763488,"marketCap":429971264},{"date":"2023-06-02","current":12.350999,"twenty":2.849018,"median":4.759848,"eighty":9.779674,"marketCap":439040970},{"date":"2023-06-09","current":12.379349,"twenty":2.849018,"median":4.759848,"eighty":9.827127,"marketCap":440048715},{"date":"2023-06-16","current":12.606146,"twenty":2.849018,"median":4.759848,"eighty":9.856526,"marketCap":448110676},{"date":"2023-06-23","current":12.001354,"twenty":2.845144,"median":4.758758,"eighty":9.889163,"marketCap":426612113},{"date":"2023-06-30","current":12.218701,"twenty":2.841271,"median":4.757669,"eighty":9.995945,"marketCap":434338159},{"date":"2023-07-07","current":12.350999,"twenty":2.841271,"median":4.757669,"eighty":10.0431,"marketCap":439040970},{"date":"2023-07-14","current":12.804594,"twenty":2.841271,"median":4.757669,"eighty":10.146489,"marketCap":455164892},{"date":"2023-07-21","current":12.653396,"twenty":2.841271,"median":4.757669,"eighty":10.21671,"marketCap":449790251},{"date":"2023-07-28","current":12.889643,"twenty":2.841271,"median":4.757669,"eighty":10.303439,"marketCap":458188128},{"date":"2023-08-04","current":13.863455,"twenty":2.841271,"median":4.760914,"eighty":10.38624,"marketCap":447761866},{"date":"2023-08-11","current":13.727024,"twenty":2.841271,"median":4.780386,"eighty":10.532089,"marketCap":443355429},{"date":"2023-08-18","current":13.349216,"twenty":2.841271,"median":4.799858,"eighty":10.576927,"marketCap":431152986},{"date":"2023-08-25","current":13.275754,"twenty":2.841271,"median":4.818035,"eighty":10.611176,"marketCap":428780288},{"date":"2023-09-01","current":13.496142,"twenty":2.841271,"median":4.838802,"eighty":10.644141,"marketCap":435898380},{"date":"2023-09-08","current":13.191796,"twenty":2.841271,"median":4.843064,"eighty":10.693073,"marketCap":426068634},{"date":"2023-09-15","current":13.611583,"twenty":2.841271,"median":4.879442,"eighty":10.741875,"marketCap":439626904},{"date":"2023-09-22","current":13.307238,"twenty":2.841271,"median":4.89625,"eighty":10.795325,"marketCap":429797159},{"date":"2023-09-29","current":13.422679,"twenty":2.841271,"median":4.900371,"eighty":10.863075,"marketCap":433525683},{"date":"2023-10-06","current":13.160312,"twenty":2.841271,"median":4.91831,"eighty":10.957851,"marketCap":425051764},{"date":"2023-10-13","current":13.22328,"twenty":2.841271,"median":4.9213,"eighty":10.997274,"marketCap":427085505},{"date":"2023-10-20","current":13.097344,"twenty":2.841271,"median":4.93326,"eighty":11.036696,"marketCap":423018024},{"date":"2023-10-27","current":13.905434,"twenty":-4.751947,"median":4.942229,"eighty":11.058772,"marketCap":449117693},{"date":"2023-11-03","current":6.329518,"twenty":-4.751947,"median":4.945558,"eighty":11.090762,"marketCap":484708152},{"date":"2023-11-10","current":6.418043,"twenty":-4.751947,"median":4.954189,"eighty":11.090762,"marketCap":491487287},{"date":"2023-11-17","current":6.528699,"twenty":-4.751947,"median":4.967255,"eighty":11.090762,"marketCap":499961206},{"date":"2023-11-24","current":6.564108,"twenty":-4.751947,"median":4.974465,"eighty":11.090762,"marketCap":502672860},{"date":"2023-12-01","current":6.360502,"twenty":-4.751947,"median":5.008006,"eighty":11.090762,"marketCap":487080849},{"date":"2023-12-08","current":6.245419,"twenty":-0.957275,"median":5.012008,"eighty":11.090762,"marketCap":478267974},{"date":"2023-12-15","current":6.329518,"twenty":-0.957275,"median":5.025945,"eighty":11.090762,"marketCap":484708152},{"date":"2023-12-22","current":6.227714,"twenty":-0.941781,"median":5.037905,"eighty":11.090762,"marketCap":476912147},{"date":"2023-12-29","current":6.280829,"twenty":-4.649297,"median":5.046648,"eighty":11.090762,"marketCap":480979628},{"date":"2024-01-05","current":6.555256,"twenty":-8.408461,"median":5.049864,"eighty":11.090762,"marketCap":501994946},{"date":"2024-01-12","current":6.533125,"twenty":-8.350357,"median":5.062066,"eighty":11.090762,"marketCap":500300163},{"date":"2024-01-19","current":6.404764,"twenty":-12.24316,"median":5.083359,"eighty":11.090762,"marketCap":490470417},{"date":"2024-01-26","current":6.400338,"twenty":-8.314204,"median":5.105866,"eighty":11.090762,"marketCap":490131460},{"date":"2024-02-02","current":6.236567,"twenty":-8.274177,"median":5.159052,"eighty":11.090762,"marketCap":477590060},{"date":"2024-02-09","current":7.254842,"twenty":-8.259974,"median":5.194658,"eighty":11.090762,"marketCap":488823979},{"date":"2024-02-16","current":7.585091,"twenty":-8.259974,"median":5.216905,"eighty":11.090762,"marketCap":511075878},{"date":"2024-02-23","current":7.649011,"twenty":-8.259974,"median":5.234138,"eighty":11.090762,"marketCap":515382697},{"date":"2024-03-01","current":7.329414,"twenty":-4.321979,"median":5.257691,"eighty":11.090762,"marketCap":493848601},{"date":"2024-03-08","current":7.403987,"twenty":-4.321979,"median":5.313308,"eighty":11.090762,"marketCap":498873224},{"date":"2024-03-15","current":7.3667,"twenty":-4.321979,"median":5.370779,"eighty":11.090762,"marketCap":496360912},{"date":"2024-03-22","current":7.425293,"twenty":-4.321979,"median":5.391172,"eighty":11.090762,"marketCap":500308830},{"date":"2024-03-28","current":7.537152,"twenty":-4.321979,"median":5.404149,"eighty":11.090762,"marketCap":507845764},{"date":"2024-04-05","current":7.340067,"twenty":-8.259974,"median":5.454205,"eighty":11.090762,"marketCap":494566404},{"date":"2024-04-12","current":7.483886,"twenty":-8.259974,"median":5.509822,"eighty":11.090762,"marketCap":504256748},{"date":"2024-04-19","current":7.435946,"twenty":-8.259974,"median":5.554316,"eighty":11.090762,"marketCap":501026633},{"date":"2024-04-26","current":7.526499,"twenty":-4.321979,"median":5.600664,"eighty":11.090762,"marketCap":507127960},{"date":"2024-05-03","current":7.574438,"twenty":-4.321979,"median":5.698921,"eighty":11.090762,"marketCap":510358075},{"date":"2024-05-10","current":6.059942,"twenty":-4.321979,"median":5.873011,"eighty":11.090762,"marketCap":516943318},{"date":"2024-05-17","current":6.10295,"twenty":-4.321979,"median":5.965462,"eighty":11.090762,"marketCap":520612184},{"date":"2024-05-24","current":5.896508,"twenty":-4.321979,"median":6.029687,"eighty":11.090762,"marketCap":503001624},{"date":"2024-05-31","current":5.999729,"twenty":-4.321979,"median":6.029687,"eighty":11.090762,"marketCap":511806904},{"date":"2024-06-07","current":6.068543,"twenty":-4.298738,"median":6.044508,"eighty":11.090762,"marketCap":517677091},{"date":"2024-06-14","current":5.999729,"twenty":-8.244479,"median":6.059942,"eighty":11.090762,"marketCap":511806904},{"date":"2024-06-21","current":5.900809,"twenty":-12.190221,"median":6.064243,"eighty":11.090762,"marketCap":503368511},{"date":"2024-06-28","current":6.055641,"twenty":-16.392329,"median":6.068543,"eighty":11.091843,"marketCap":516576431},{"date":"2024-07-05","current":6.081446,"twenty":-16.392329,"median":6.07662,"eighty":11.091843,"marketCap":518777751},{"date":"2024-07-12","current":6.047039,"twenty":-16.392329,"median":6.07662,"eighty":11.091843,"marketCap":515842658},{"date":"2024-07-15","current":6.133057,"twenty":-16.392329,"median":6.077145,"eighty":11.091843,"marketCap":523180391},{"date":"2024-08-02","current":6.008331,"twenty":-16.946532,"median":6.095365,"eighty":11.132887,"marketCap":512540677},{"date":"2024-08-09","current":6.672763,"twenty":-16.946532,"median":6.118468,"eighty":11.132887,"marketCap":467046730},{"date":"2024-08-16","current":6.903401,"twenty":-16.946532,"median":6.137357,"eighty":11.132887,"marketCap":483189744},{"date":"2024-08-23","current":6.78284,"twenty":-16.946532,"median":6.192305,"eighty":11.132887,"marketCap":474751350},{"date":"2024-08-30","current":6.725181,"twenty":-16.946532,"median":6.234354,"eighty":11.132887,"marketCap":470715597},{"date":"2024-09-06","current":6.641313,"twenty":-16.946532,"median":6.266209,"eighty":11.132887,"marketCap":464845410},{"date":"2024-09-13","current":6.657038,"twenty":-16.946532,"median":6.314998,"eighty":11.132887,"marketCap":465946070},{"date":"2024-09-20","current":7.144522,"twenty":-16.946532,"median":6.332753,"eighty":11.132887,"marketCap":500066531},{"date":"2024-09-27","current":7.40661,"twenty":-16.946532,"median":6.371197,"eighty":11.132887,"marketCap":518410864},{"date":"2024-10-04","current":7.76305,"twenty":-16.946532,"median":6.38746,"eighty":11.132887,"marketCap":543359158},{"date":"2024-10-11","current":7.102588,"twenty":-16.946532,"median":6.404764,"eighty":11.132887,"marketCap":497131437},{"date":"2024-10-18","current":7.438061,"twenty":-16.946532,"median":6.418043,"eighty":11.132887,"marketCap":520612184},{"date":"2024-10-25","current":7.380401,"twenty":-16.946532,"median":6.453453,"eighty":11.132887,"marketCap":516576431},{"date":"2024-10-31","current":7.212665,"twenty":-16.946532,"median":6.504354,"eighty":11.132887,"marketCap":504836057},{"date":"2024-11-08","current":7.233632,"twenty":-16.957842,"median":6.506567,"eighty":11.090762,"marketCap":506303604},{"date":"2024-11-15","current":13.157063,"twenty":-16.957842,"median":6.506567,"eighty":11.090762,"marketCap":501534077},{"date":"2024-11-22","current":12.993442,"twenty":-16.957842,"median":6.506567,"eighty":11.090762,"marketCap":495297004},{"date":"2024-11-29","current":13.147438,"twenty":-16.957842,"median":6.506567,"eighty":11.090762,"marketCap":501167191},{"date":"2024-12-06","current":13.108939,"twenty":-16.957842,"median":6.506567,"eighty":11.090762,"marketCap":499699644},{"date":"2024-12-13","current":13.080065,"twenty":-16.957842,"median":6.506567,"eighty":11.090762,"marketCap":498598984},{"date":"2024-12-20","current":12.589201,"twenty":-16.957842,"median":6.506567,"eighty":11.090762,"marketCap":479887764},{"date":"2024-12-27","current":12.637325,"twenty":-16.957842,"median":6.506567,"eighty":11.090762,"marketCap":481722197},{"date":"2025-01-03","current":12.743198,"twenty":-16.957842,"median":6.506567,"eighty":11.090762,"marketCap":485757951},{"date":"2025-01-10","current":12.473704,"twenty":-16.969152,"median":6.506567,"eighty":11.087653,"marketCap":475485124},{"date":"2025-01-17","current":12.781697,"twenty":-16.969152,"median":6.506567,"eighty":11.087653,"marketCap":487225497},{"date":"2025-01-24","current":12.877944,"twenty":-16.969152,"median":6.506567,"eighty":11.087653,"marketCap":490894364},{"date":"2025-01-31","current":12.86832,"twenty":-16.969152,"median":6.506567,"eighty":11.087653,"marketCap":490527477},{"date":"2025-02-07","current":13.022316,"twenty":-16.969152,"median":6.506567,"eighty":11.087653,"marketCap":496397664},{"date":"2025-02-14","current":7.280156,"twenty":-16.969152,"median":6.506567,"eighty":11.08558,"marketCap":509829353},{"date":"2025-02-21","current":7.243335,"twenty":-16.969152,"median":6.506567,"eighty":11.041427,"marketCap":507250736},{"date":"2025-02-28","current":7.164431,"twenty":-16.969152,"median":6.506567,"eighty":11.00433,"marketCap":501725129},{"date":"2025-03-07","current":6.996104,"twenty":-16.980463,"median":6.506567,"eighty":10.956274,"marketCap":489937167},{"date":"2025-03-14","current":6.880379,"twenty":-16.980463,"median":6.506567,"eighty":10.956274,"marketCap":481832943},{"date":"2025-03-21","current":7.13813,"twenty":-16.980463,"median":6.506567,"eighty":10.956274,"marketCap":499883260},{"date":"2025-03-28","current":7.164431,"twenty":-16.980463,"median":6.506567,"eighty":10.956274,"marketCap":501725129},{"date":"2025-04-04","current":6.996104,"twenty":-16.980463,"median":6.506567,"eighty":10.956274,"marketCap":489937167},{"date":"2025-04-11","current":6.68049,"twenty":-16.969152,"median":6.497715,"eighty":10.954698,"marketCap":467834738},{"date":"2025-04-17","current":7.201253,"twenty":-16.969152,"median":6.497715,"eighty":10.954698,"marketCap":504303745},{"date":"2025-04-25","current":7.306458,"twenty":-16.980463,"median":6.493289,"eighty":10.956274,"marketCap":511671222},{"date":"2025-05-02","current":7.164431,"twenty":-16.980463,"median":6.493289,"eighty":10.912121,"marketCap":501725129},{"date":"2025-05-08","current":7.243335,"twenty":-16.980463,"median":6.493289,"eighty":10.895978,"marketCap":507250736}],"updateTime":1746794295603}}}